TISLELIZUMAB
Manner of administration:Injection
Restriction (Streamlined authority code: 16375)
Indication: Advanced or metastatic gastro-oesophageal cancer
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 200 mg | # of repeats: 7 | DPMA: $6,483.47 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Tevimbra
(tislelizumab 100 mg/10 mL injection, 10 mL vial)
|
||||
Manner of administration:Injection
Restriction (Streamlined authority code: 16375)
Indication: Advanced or metastatic gastro-oesophageal cancer
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 200 mg | # of repeats: 7 | DPMA: $6,618.64 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Tevimbra
(tislelizumab 100 mg/10 mL injection, 10 mL vial)
|
||||
